Kepos Capital’s Genomic Health, Inc. GHDX Stock Holding History

Kepos Capital’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,443	Closed	-$1.11M	–	458
2019 Q3	$1.11M	Sell	16,443 -32,450	-66%	-$2.23M	0.11%	89
2019 Q2	$2.84M	Sell	48,893 -8,507	-15%	-$504K	0.29%	60
2019 Q1	$4.02M	Buy	57,400 +49	+0.1%	+$3.63K	0.3%	105
2018 Q4	$3.69M	Buy	57,351 +30,800	+116%	+$2.16M	0.29%	106
2018 Q3	$1.86M	Buy	+26,551	New	+$1.55M	0.1%	170

Kepos Capital's GHDX Position: Q4 2019 in Review

Kepos Capital sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 16,443 shares — an estimated $1.11M sold.

Kepos Capital first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $4.02M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Kepos Capital reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Kepos Capital sold 16,443 Genomic Health, Inc. shares in Q4 2019, an estimated $1.11M.
Kepos Capital first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Kepos Capital's Genomic Health, Inc. position peaked at $4.02M in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Kepos Capital's 13F filing for Q4 2019, filed 13 Feb 2020.